RENATA ROBERTSON: Open Payments
NPI 1740646348 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 27 payments from 15 companies in 2025. Trend: 2023 $720 · 2024 $567 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $176 |
| E.R. Squibb & Sons, L.L.C. | 6 | $162 |
| Janssen Biotech, Inc. | 1 | $148 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Genentech USA, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Exelixis Inc. | 1 | $34 |
| BeOne Medicines USA, Inc. | 1 | $26 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
Products named: OPDIVO, RYBREVANT, EPKINLY, Polivy, PLUVICTO, FRUZAQLA, CABOMETYX, VENCLEXTA.
Industry payments across IN — which companies pay providers there.
